Phathom Pharmaceuticals Company Insiders

Phathom Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.5767) % which means that it has lost $0.5767 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (34.89) %, meaning that it created substantial loss on money invested by shareholders. Phathom Pharmaceuticals' management efficiency ratios could be used to measure how well Phathom Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 2.91 in 2024, whereas Return On Tangible Assets are likely to drop (0.51) in 2024. At this time, Phathom Pharmaceuticals' Non Current Liabilities Total is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 325 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 26.7 M in 2024. Common Stock Shares Outstanding is likely to drop to about 35.6 M in 2024. Net Loss is likely to drop to about (186.8 M) in 2024

Phathom Pharmaceuticals Workforce Comparison

Phathom Pharmaceuticals Insider Trading History

Phathom Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Phathom Pharmaceuticals often depends on how effective the management is. Phathom Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Phathom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Phathom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Phathom Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phathom Pharmaceuticals. Check Phathom Pharmaceuticals' Beneish M Score to see the likelihood of Phathom Pharmaceuticals' management manipulating its earnings.

When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.